ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...
Gilead to present HIV research findings at conference
Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...
Morningstar4d
ViiV Healthcare expands on real-world data supporting use of long-acting therapies in diverse patient populations at HIV Glasgow
Key data to be presented at HIV Glasgow 2024 by ViiV Healthcare and its study partners will include: Analysis of cabotegravir + rilpivirine long-acting (CAB+RPV LA) in the real-world and across ...
HIV positive pilot goes public in bid to tackle stigma
James Bushe had previously wanted to remain anonymous, using the pseudonym "Pilot Anthony" on Twitter to write about his ...
BBC1y
I Kissed a Boy star Dan Harry signs up for HIV vaccine trial
A contestant who appeared on the UK's first gay dating show is taking part in a new HIV vaccine trial. Dan Harry, from Coatbridge, has volunteered for tests which will see him exposed to a ...
Hosted on MSN1mon
Glasgow's safer drug consumption room opening delayed until UK-first facility passes checks
The facility was due to open on October 21 but Glasgow City Council said this has ... were first proposed in the city in 2016 following an HIV outbreak among drug users, but became entangled ...
Yahoo Finance4d
Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
"Our contributions to HIV Glasgow 2024 demonstrate that people are at the center of all we do at Gilead. The breadth and depth of Gilead’s work underscore our commitment to driving the next wave ...